The Biden Administration’s Failed Fight against Fentanyl

The White House recognizes the problem but is trying to solve it with yesterday’s methods.

Share this story

A man holds up a bag of what he says is fentanyl across the street from where San Francisco mayor London Breed just held a news conference introducing legislation to curb the rise of deadly overdoses in the city, in the Tenderloin district of San Francisco, Calif., February 27, 2020.

Shannon Stapleton/Reuters

Last week, after two Ohio State students perished of suspected drug overdoses, the university alerted students to “fake Adderall pills” circulating on campus that appear to contain the synthetic opioid fentanyl. Importantly, these deaths come on the heels of new provisional data from the Centers for Disease Control and Prevention indicating that the number of predicted overdose deaths in 2021 surpassed 107,000, a new record.

Unfortunately, a National Drug Control Strategy (NDCS) released by the Biden administration in April leaves little room for optimism. The document has major shortcomings that undermine its ability to defeat the deadly threat of illicit drugs. While the NDCS acknowledges the recent spike in deaths from overdoses, it does not pivot resources, nor enforcement and management efforts, toward cutting the supply of those drugs most responsible for the higher death toll: illicitly produced synthetic opioids, like the fentanyl apparently present in the fake Adderall plaguing Ohio State.

RL

About the Author

Randall Lutter

Randall Lutter is a senior fellow at the Manhattan Institute and author of the recent issue brief “Fighting Fentanyl: The Biden Administration’s Failure of Leadership.”

Comments

Advertisement

Advertisement